Pharmaceuticals in wastewater: behavior, preferences, and willingness to pay for a disposal program.

The presence of pharmaceutical compounds in treated wastewater and in surface waters is a growing environmental concern. This paper provides information about general awareness of the issue, disposal practices, willingness to pay for a disposal program, and willingness to participate in a disposal program. The results are based on a telephone survey of 1005 residents in southern California. Less than half of the respondents are aware of the issue. While disposal of unused medications through the trash and toilet/sink is the most common practices, respondents that are aware of the issue are more likely to return pharmaceuticals to a pharmacy or drop them off at a hazardous waste center. The results of a contingent valuation question indicate a substantial willingness to pay a surcharge on prescriptions to support the establishment of a pharmaceutical disposal program. The more conservative estimate of mean willingness to pay is $1.53 per prescription, which translates into an average annual willingness to pay of approximately $14. A benefit-cost comparison suggests ample scope for establishing a pharmaceutical disposal program that would yield positive net social benefits, even if the surcharge was applied to only one prescription per year. We also find that respondents are likely to participate in a disposal program. Assuming that the program is based on drop-off locations at local pharmacies, approximately 70 percent of the respondents would be very likely to return their unwanted or expired medicines.

Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain.

Bone morphogenetic protein-4 (BMP-4) is synthesized as a large precursor protein, which undergoes proprotein convertase-mediated proteolytic maturation along the secretory pathway to release the active ligand. Pro-BMP-4 is initially cleaved at a consensus furin motif adjacent to the mature ligand domain (the S1 site), and this allows for subsequent cleavage at an upstream motif (the S2 site). This sequential cleavage liberates a small, evolutionarily conserved, prodomain fragment (the linker peptide) of unknown fate and function. Here we show that the linker domain is essential for proper folding, exit from the endoplasmic reticulum, and thus cleavage of the BMP-4 precursor when overexpressed in Xenopus oocytes and embryos but not in cultured mammalian cells. Mature BMP-4 synthesized from a precursor in which the S1 site is non-cleavable, such that the linker domain remains covalently attached to the ligand, has little or no activity in vivo. Finally, analysis of folding, cleavage, and bioactivity of chimeric precursors containing the BMP-7 prodomain and BMP-4 mature domain, or vice versa, with or without the BMP-4 linker domain revealed that the linker domain is only functional in the context of the BMP-4 prodomain, and that differential cleavage around this domain can regulate the activity of a heterologous ligand.

Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity.

ProBMP4 is initially cleaved at a site adjacent to the mature ligand (the S1 site) allowing for subsequent cleavage at an upstream (S2) site. Mature BMP4 synthesized from a precursor in which the S2 site cannot be cleaved remains in a complex with the prodomain that is targeted for lysosomal degradation, and is thus less active when overexpressed in Xenopus. Here we report that mice carrying a point mutation that prevents S2 processing show severe loss of BMP4 activity in some tissues, such as testes and germ cells, whereas other tissues that are sensitive to Bmp4 dosage, such as the limb, dorsal vertebrae and kidney, develop normally. In a haploinsufficient background, inability to cleave the S2 site leads to embryonic and postnatal lethality due to defects in multiple organ systems including the allantois, placental vasculature, ventral body wall, eye and heart. These data demonstrate that cleavage of the S2 site is essential for normal development and, more importantly, suggest that this site might be selectively cleaved in a tissue-specific fashion. In addition, these studies provide the first genetic evidence that BMP4 is required for dorsal vertebral fusion and closure of the ventral body wall.

Proprotein convertase genes in Xenopus development.

Proprotein convertases (PCs) are a family of serine endoproteases that proteolytically activate many precursor proteins within various secretory pathway compartments. Loss-of-function studies have demonstrated a critical role for these proteases in embryonic patterning and adult homeostasis, yet little is known about how substrate selectivity is achieved. We have identified Xenopus orthologs of three PCs: furin, PC6, and PC4. In addition to previously described isoforms of PC6 and furin, four novel splice isoforms of PC6, which are predicted to encode constitutively secreted proteases, and a putative transmembrane isoform of PC4 were identified. Furin and PC6 are expressed in dynamic, tissue-specific patterns throughout embryogenesis, whereas PC4 transcripts are restricted primarily to germ cells and brain in adult frogs.